Business · 31/03/2022
FDA Extends Comment Period for Public Hearing on New Animal Drug Carbadox
The FDA is extending the comment period for a public hearing on the new animal drug carbadox, following a request for an extension from interested persons, in response to a notice published in the Federal Register on January 13, 2022.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →